fda glp-1 compounding crackdown news october 2025 Intensifies on Despite FDA crackdown, unapproved GLP-1s

In this stage of life, your metabolism, hormone levels, and symptom severity are unique, meaning a personalized approach is critical

For women with lipoedema who already commonly present with digestive issues, histamine intolerance, MCAS, reflux associated with hiatus hernia, or who wear compression garments that fit around the abdomen, which can place upward pressure on the stomach, this cascade of gastrointestinal complications is a very real and underacknowledged risk that needs consideration before starting these medications

Please confirm with your health professional

SGLT-2 inhibitors carry the sharper version of this, the risk of diabetic ketoacidosis, which is why they are used only under strict protocols